
Marksans Pharma Ltd
NSE:MARKSANS

Marksans Pharma Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
141.5
353.4
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Marksans Pharma Ltd hold over its rivals?
What risks and challenges
does Marksans Pharma Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Marksans Pharma Ltd.
Provide an overview of the primary business activities
of Marksans Pharma Ltd.
What unique competitive advantages
does Marksans Pharma Ltd hold over its rivals?
What risks and challenges
does Marksans Pharma Ltd face in the near future?
Has there been any significant insider trading activity
in Marksans Pharma Ltd recently?
Summarize the latest earnings call
of Marksans Pharma Ltd.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Marksans Pharma Ltd.
Provide P/S
for Marksans Pharma Ltd.
Provide P/E
for Marksans Pharma Ltd.
Provide P/OCF
for Marksans Pharma Ltd.
Provide P/FCFE
for Marksans Pharma Ltd.
Provide P/B
for Marksans Pharma Ltd.
Provide EV/S
for Marksans Pharma Ltd.
Provide EV/GP
for Marksans Pharma Ltd.
Provide EV/EBITDA
for Marksans Pharma Ltd.
Provide EV/EBIT
for Marksans Pharma Ltd.
Provide EV/OCF
for Marksans Pharma Ltd.
Provide EV/FCFF
for Marksans Pharma Ltd.
Provide EV/IC
for Marksans Pharma Ltd.
Show me price targets
for Marksans Pharma Ltd made by professional analysts.
What are the Revenue projections
for Marksans Pharma Ltd?
How accurate were the past Revenue estimates
for Marksans Pharma Ltd?
What are the Net Income projections
for Marksans Pharma Ltd?
How accurate were the past Net Income estimates
for Marksans Pharma Ltd?
What are the EPS projections
for Marksans Pharma Ltd?
How accurate were the past EPS estimates
for Marksans Pharma Ltd?
What are the EBIT projections
for Marksans Pharma Ltd?
How accurate were the past EBIT estimates
for Marksans Pharma Ltd?
Compare the revenue forecasts
for Marksans Pharma Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Marksans Pharma Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Marksans Pharma Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of Marksans Pharma Ltd compared to its peers.
Compare the P/E ratios
of Marksans Pharma Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing Marksans Pharma Ltd with its peers.
Analyze the financial leverage
of Marksans Pharma Ltd compared to its main competitors.
Show all profitability ratios
for Marksans Pharma Ltd.
Provide ROE
for Marksans Pharma Ltd.
Provide ROA
for Marksans Pharma Ltd.
Provide ROIC
for Marksans Pharma Ltd.
Provide ROCE
for Marksans Pharma Ltd.
Provide Gross Margin
for Marksans Pharma Ltd.
Provide Operating Margin
for Marksans Pharma Ltd.
Provide Net Margin
for Marksans Pharma Ltd.
Provide FCF Margin
for Marksans Pharma Ltd.
Show all solvency ratios
for Marksans Pharma Ltd.
Provide D/E Ratio
for Marksans Pharma Ltd.
Provide D/A Ratio
for Marksans Pharma Ltd.
Provide Interest Coverage Ratio
for Marksans Pharma Ltd.
Provide Altman Z-Score Ratio
for Marksans Pharma Ltd.
Provide Quick Ratio
for Marksans Pharma Ltd.
Provide Current Ratio
for Marksans Pharma Ltd.
Provide Cash Ratio
for Marksans Pharma Ltd.
What is the historical Revenue growth
over the last 5 years for Marksans Pharma Ltd?
What is the historical Net Income growth
over the last 5 years for Marksans Pharma Ltd?
What is the current Free Cash Flow
of Marksans Pharma Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for Marksans Pharma Ltd.
MARKSANS's latest stock split occurred on Mar 11, 2008
The company executed a 10-for-1 stock split, meaning that for every share held, investors received 10 new shares.
The adjusted shares began trading on Mar 11, 2008. This was the only stock split in MARKSANS's history.
Global
Stock Splits Monitor
Marksans Pharma Ltd
Glance View
Marksans Pharma Ltd. is a prominent player in the global pharmaceutical landscape, with its roots deeply embedded in the meticulous world of drug formulation and manufacturing. The company weaves its narrative through a robust portfolio that spans various therapeutic segments, including pain management, oncology, cardiovascular health, and anti-diabetic medications. By navigating the complexities of regulated markets such as the United States, the United Kingdom, and Australia, Marksans has engineered a business model that emphasizes quality, compliance, and innovation. This framework allows the company not only to design and develop a diverse array of generic pharmaceutical products but also to efficiently cater to a global clientele through its cost-effective yet high-quality manufacturing processes. Central to Marksans' success is its strategic integration of research and development with flexible manufacturing capabilities, housed in state-of-the-art facilities across Goa and India. These facilities, certified by leading international regulatory bodies, enable Marksans to maintain a competitive edge in both product delivery and diversification. By leveraging strategic partnerships and continuously expanding its product portfolio, it thrives in the dynamic pharmaceutical market. Revenue generation flows seamlessly through its vertically integrated operations, which streamline the journey from drug conception to distribution. Through these concerted efforts, Marksans not only bolsters its financial standing but also contributes significantly to the broader field of global healthcare, aligning economic performance with a commitment to health and well-being.
